[go: up one dir, main page]

AU2003202112A1 - Bioavailability enhancing activity of carum carvi extracts and fractions thereof - Google Patents

Bioavailability enhancing activity of carum carvi extracts and fractions thereof

Info

Publication number
AU2003202112A1
AU2003202112A1 AU2003202112A AU2003202112A AU2003202112A1 AU 2003202112 A1 AU2003202112 A1 AU 2003202112A1 AU 2003202112 A AU2003202112 A AU 2003202112A AU 2003202112 A AU2003202112 A AU 2003202112A AU 2003202112 A1 AU2003202112 A1 AU 2003202112A1
Authority
AU
Australia
Prior art keywords
fractions
extracts
enhancing activity
bioavailability enhancing
carum carvi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003202112A
Other versions
AU2003202112A8 (en
Inventor
Tasduq Abdullah
Kasturi Lal Bedi
Bishan Datt Gupta
Rakesh Kamal Johri
Ravi Kant Khajuria
Ghulam Nabi Qafi
Naresh Kumar Satti
Subhash Chander Sharma
Krishan Avtar Suri
Om Prakash Suri
Ashok Kumar Tikoo
Manoj Kumar Tikoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of AU2003202112A8 publication Critical patent/AU2003202112A8/en
Publication of AU2003202112A1 publication Critical patent/AU2003202112A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2003202112A 2003-01-30 2003-01-30 Bioavailability enhancing activity of carum carvi extracts and fractions thereof Abandoned AU2003202112A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2003/000293 WO2004067018A1 (en) 2003-01-30 2003-01-30 Bioavailability enhancing activity of carum carvi extracts and fractions thereof

Publications (2)

Publication Number Publication Date
AU2003202112A8 AU2003202112A8 (en) 2004-08-23
AU2003202112A1 true AU2003202112A1 (en) 2004-08-23

Family

ID=32800536

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003202112A Abandoned AU2003202112A1 (en) 2003-01-30 2003-01-30 Bioavailability enhancing activity of carum carvi extracts and fractions thereof

Country Status (5)

Country Link
EP (1) EP1587521A1 (en)
JP (1) JP2006514962A (en)
CN (1) CN1738632A (en)
AU (1) AU2003202112A1 (en)
WO (1) WO2004067018A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080181947A1 (en) 2006-09-26 2008-07-31 Astellas Pharma Inc. Controlled release dosage form of tacrolimus
US20090011018A1 (en) 2006-12-28 2009-01-08 Astellas Pharma Inc., Sustained release formulation for tacrolimus
CN102133385A (en) * 2011-03-02 2011-07-27 青岛大学 Ginger and white pepper composition, preparation method thereof and application thereof to preparation of medicaments for attenuation and synergia in cancer radiochemotherapy
CN102757865B (en) * 2011-04-25 2013-06-05 湖北中烟工业有限责任公司 Carum carvi and dried ginger composite extract and purpose thereof as tobacco product additive
FR2979826B1 (en) * 2011-09-08 2013-12-27 Univ Bordeaux Segalen ANTI-INFLAMMATORY COMPOSITION
ES2902136T3 (en) * 2016-02-12 2022-03-25 Cipla Ltd Pharmaceutical compositions comprising an antiretroviral drug and a pharmacokinetic enhancer
IT201600075072A1 (en) * 2016-07-18 2018-01-18 Nathura S P A Pharmaceutical or dietary supplement composition for the treatment of intestinal constipation
CN108205032A (en) * 2017-12-29 2018-06-26 佛山市南海东方澳龙制药有限公司 The detection method of ketoconazole ingredient liquid content in a kind of compound ketoconazole ointment
US20210299203A1 (en) * 2020-03-26 2021-09-30 Johnson & Johnson Consumer Inc. Compositions comprising carum carvi and rosmarinus officinalis extracts and methods of using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3511862A1 (en) * 1985-04-01 1986-10-09 Klinge Co Chem Pharm Fab Pharmaceutical composition
DE69131646T2 (en) * 1990-03-02 2000-03-02 The Partnership Of Isaac G. Eliaz And Samuel Gonen, San Anselmo METHOD AND MEANS FOR PROMOTING HAIR GROWTH AND IMPROVING THE SKIN CONDITION
ES2153362T3 (en) * 1991-08-26 2001-03-01 Abbott Lab COMPOSITIONS AND PROCEDURES OF SUBLINGUAL OR BUCAL ADMINISTRATION OF THERAPEUTIC AGENTS.
JP2946452B2 (en) * 1994-11-04 1999-09-06 カディラ ラボラトリーズ リミテッド Composition containing piperine
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
WO1996040192A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
CH688787A5 (en) * 1995-09-05 1998-03-31 Dieter Linsig Synergistic mixture of essential oils or essences
IN186315B (en) * 1996-12-12 2001-08-04 Panacea Biotec Ltd
DE10022801A1 (en) * 2000-05-10 2001-11-15 Ernestina C Loeckinger Well tolerated natural medicament for treating urological, gynecological or intestinal diseases, comprising black caraway oil, tea tree oil and grapefruit seed extract.
AU2001278849A1 (en) * 2000-05-19 2001-12-03 Sabinsa Corporation Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives
JP2002138045A (en) * 2000-10-30 2002-05-14 Ichimaru Pharcos Co Ltd Inhibitor for inhibiting differentiation induction of pre- adipocyte
JP2003095915A (en) * 2001-09-25 2003-04-03 Shiseido Co Ltd Skin care composition

Also Published As

Publication number Publication date
WO2004067018A1 (en) 2004-08-12
JP2006514962A (en) 2006-05-18
WO2004067018A8 (en) 2006-02-23
CN1738632A (en) 2006-02-22
AU2003202112A8 (en) 2004-08-23
EP1587521A1 (en) 2005-10-26

Similar Documents

Publication Publication Date Title
EP1501514A4 (en) Protein kinase modulators and methods of use
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
PL362515A1 (en) Analysis of business innovation potential
AU2001234608A1 (en) Methods for analysis of gene expression
AU2003231856A1 (en) Financial instruments and methods
AU2003286004A1 (en) Single domain antibodies directed against interferon- gamma and uses therefor
WO2003059257A8 (en) Anti-angiogenic proteins and fragmentsand methods of use thereof
AU2002366588A1 (en) Bioavailability enhancing activity of zingiber officinale linn and its extracts/fractions thereof
WO2003058354A8 (en) Global equation solver and optimizer
AU2003206882A1 (en) Analysis of vital substances
AU2003202112A1 (en) Bioavailability enhancing activity of carum carvi extracts and fractions thereof
AU2003241370A1 (en) Waveform analysis
AU2004285983A8 (en) HBV variants detection and application
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003221427A1 (en) Oily makeup cosmetics
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2002241185A1 (en) Quantitative detection of the conformation changes of p-glycoprotein
AU2003252075A1 (en) Human immunosuppressive protein
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001270209A1 (en) Hiv-1 vaccines and screening methods therefor
AU2003210035A1 (en) Enhanced inserted yellow fluorescence protein and its application
AU2002243679A1 (en) Cub domain protein zcub3 and materials and methods for making it
AU2002326718A1 (en) Tramdorins and methods of using tramdorins
AU2003241827A1 (en) Antibody capable of recognizing 8-nitroguanine
AU2002322702A1 (en) Grifola extracts and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase